Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

NatWest lifts guidance, reveals £750m share buyback

(Sharecast News) - NatWest Bank on Friday posted slightly better-than-expected interim results and announced a new £750m share buyback. Operating pre-tax profit for six months to June 30 rose 18% to £3.6bn, beating the £3.46bn average forecast by analysts. The bank, reporting first results since its return to private ownership, lifted its dividend by 58% to 9.5p a share.

NatWest said it now expected to achieve a return on tangible equity of 16.5%, from previous guidance of up to 16%. It also forecast annual income to be above £16bn, up from earlier guidance of £15.2bn - £15.7bn.

Provisions for bad loans came in at £193m, lower than the £226mn analysts expected. Income rose to £7.9bn compared from £7.1bn a year ago as lending and customer numbers rose.

NatWest in May announced its return to full private ownership, after an expensive taxpayer bailout in 2008 when banking industry malfeasance sparked the global financial crash.

"NatWest has given investors reason to cheer heading into the weekend with a broad-based beat this morning. It's a similar story to Lloyds yesterday, with better impairments doing most of the work to bring profits in a good clip above expectations," said Hargreaves Lansdown analyst Matt Britzman.

"Unlike Lloyds, NatWest has taken the opportunity to raise its guidance, though this simply aligns management to where consensus is already sitting."

"The overarching story here is a positive one. Borrowers are looking strong, loans and deposits are growing, and costs are under control. That's providing a strong base for the bank's secret weapon, the structural hedge, to sit on top of. "

"The hedge is expected to bring home an additional £1 billion of income this year alone, as 0% products are being reinvested at yields of around 3.7%. This is a multi-year tailwind that's helping underpin a positive outlook for NatWest."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.